From: Reconsideration of the safety and effectiveness of human oocyte cryopreservation
Total Oocyte Banking Reported (Oocyte Banking reported for Fertility Preservation) | Fresh Donor Oocytes Subjected to IVF/ICSI | Cryopreserved Donor Oocytes Subjected to IVF/ICSI | ||||
---|---|---|---|---|---|---|
Year | Number of per initiated recipient cycle from all ages | Mean Percentage (%) of recipient initiated cycle resulting in live births (95% CI) from all ages | Number of per initiated recipient cycle from all ages | Mean Percentage (%) of recipient initiated cycle resulting in live births (95% CI) from all ages | P value | |
2013 | 2227 | 8,921 | 49.6% (48.6–50.6) | 2,227 | 43.2% (41.2–45.3) | < 0.001 8 |
2014 | 6090 (6090) | 6,776 | 53.3% (52.1–54.4) | 2,468 | 41.0% (39.1–43.0) | |
2015 | 7591 (7591) | 5,897 | 50.5% (49.2–51.8) | 2,803 | 40.8% (39.0–42.7) | |
2016 | 9239 (8336) | 4,409 | 50.6% (49.2–52.1) | 2,908 | 39.4% (37.7–41.2) | |
2017 | 10,955 (9607) | 3,146 | 49.2% (47.4–50.9) | 3,013 | 43.1% (41.3–44.9) | |
2018 | 14,758 (13,041) | 2,368 | 49.4% (47.4–51.4) | 3,362 | 39.1% (37.4–40.7) | |
2019 | 17,805 (15,829) | 1,776 | 44.7% (42.4–47.0) | 2,841 | 40.5% (38.7–42.4) | |
2020 | 18,323 (16,945) | 1,277 | 44.6% (41.9–47.4) | 2,541 | 41.1% (39.2–43.0) | |
Total per initiated recipient cycles from 2013–2020 | 34,570 | 22,163 | ||||
All ages mean of the mean percentages live- birth-rate from 2013–2020 | 49.0% (44.6–53.3) | 41.0% (39.1–43.2) | < 0.001 |